MoneyWorks4Me

Sanofi India - Quaterly Results

29 Apr 2026 Evaluate
The sales declined to Rs. 4723.00 millions for the March 2026 quarter as compared to Rs. 5359.00 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -14.14% to Rs. 1026.00  millions from Rs. 1195.00 millions.The Operating Profit of the company witnessed a decrease to 1472.00 millions from 1752.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202512 202412 % Var
Sales 4723.00 5359.00 -11.87 4723.00 5359.00 -11.87 18374.00 20132.00 -8.73
Other Income 44.00 33.00 33.33 44.00 33.00 33.33 197.00 165.00 19.39
PBIDT 1472.00 1752.00 -15.98 1472.00 1752.00 -15.98 5110.00 5073.00 0.73
Interest 3.00 3.00 0.00 3.00 3.00 0.00 17.00 15.00 13.33
PBDT 1469.00 1749.00 -16.01 1469.00 1749.00 -16.01 4820.00 4681.00 2.97
Depreciation 90.00 96.00 -6.25 90.00 96.00 -6.25 373.00 367.00 1.63
PBT 1379.00 1653.00 -16.58 1379.00 1653.00 -16.58 4447.00 4314.00 3.08
TAX 353.00 458.00 -22.93 353.00 458.00 -22.93 1180.00 1177.00 0.25
Deferred Tax 10.00 1.00 900.00 10.00 1.00 900.00 -49.00 -81.00 -39.51
PAT 1026.00 1195.00 -14.14 1026.00 1195.00 -14.14 3267.00 3137.00 4.14
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 31.17 32.69 -4.67 31.17 32.69 -4.67 27.81 25.20 10.37
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..